Oncology [TOI] vs Pediatrix Medical [MD] Detailed Stock Comparison

The Oncology Institute Inc.

NASDAQ
Loading...

Pediatrix Medical Group, Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: The Oncology Institute Inc. wins in 5 metrics, Pediatrix Medical Group, Inc. wins in 13 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric The Oncology Institute Inc. Pediatrix Medical Group, Inc. Better
P/E Ratio (TTM) N/A 11.88 N/A
Price-to-Book Ratio -20.91 2.16 Pediatrix Medical Group, Inc.
Debt-to-Equity Ratio -6.60 73.29 Pediatrix Medical Group, Inc.
PEG Ratio -21.50 9.90 Pediatrix Medical Group, Inc.
EV/EBITDA -14.08 7.92 Pediatrix Medical Group, Inc.
Profit Margin (TTM) -12.06% 8.64% Pediatrix Medical Group, Inc.
Operating Margin (TTM) -4.87% 11.07% Pediatrix Medical Group, Inc.
EBITDA Margin (TTM) N/A 11.07% N/A
Return on Equity 320.01% 20.28% The Oncology Institute Inc.
Return on Assets (TTM) -13.37% 6.57% Pediatrix Medical Group, Inc.
Free Cash Flow (TTM) $-27.79M $252.63M Pediatrix Medical Group, Inc.
1-Year Return 114.98% 73.57% The Oncology Institute Inc.
Price-to-Sales Ratio (TTM) 0.68 1.00 The Oncology Institute Inc.
Enterprise Value $410.19M $2.00B Pediatrix Medical Group, Inc.
EV/Revenue Ratio 0.82 1.05 The Oncology Institute Inc.
Gross Profit Margin (TTM) 16.04% 25.51% Pediatrix Medical Group, Inc.
Revenue per Share (TTM) $5 $23 Pediatrix Medical Group, Inc.
Earnings per Share (Diluted) $-0.54 $1.94 Pediatrix Medical Group, Inc.
Beta (Stock Volatility) 0.20 0.72 The Oncology Institute Inc.
Short % of Float 10.12% 6.00% Pediatrix Medical Group, Inc.

The Oncology Institute Inc. vs Pediatrix Medical Group, Inc. Stock Performance Analysis

Loading Price Chart...

TOI
MD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
The Oncology Institute Inc.-2.45%2.17%30.15%51.91%37.40%41.14%
Pediatrix Medical Group, Inc.0.29%8.46%8.36%25.04%7.40%14.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
The Oncology Institute Inc.114.98%756.45%-47.43%-46.04%-46.04%-46.04%
Pediatrix Medical Group, Inc.73.57%75.20%-20.69%-64.71%-31.34%9.12%

Performance & Financial Health Analysis: The Oncology Institute Inc. vs Pediatrix Medical Group, Inc.

MetricTOIMD
Market Information
Market Cap i$323.20M$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,461,731510,889
90 Day Avg. Volume i2,155,547755,756
Last Close$5.18$24.37
52 Week Range$2.02 - $5.57$11.84 - $24.99
% from 52W High-7.09%-2.48%
All-Time High$12.66 (Dec 27, 2021)$86.09 (Aug 17, 2015)
% from All-Time High-59.08%-71.69%
Growth Metrics
Quarterly Revenue Growth0.42%-0.02%
Quarterly Earnings Growth0.42%0.11%
Financial Health
Profit Margin (TTM) i-0.12%0.09%
Operating Margin (TTM) i-0.05%0.11%
Return on Equity (TTM) i3.20%0.20%
Debt to Equity (MRQ) i-6.6073.29
Cash & Liquidity
Book Value per Share (MRQ)$-0.16$10.68
Cash per Share (MRQ)$0.34$6.16
Operating Cash Flow (TTM) i$-24,587,000$271.09M
Levered Free Cash Flow (TTM) i$-11,004,375$190.33M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: The Oncology Institute Inc. vs Pediatrix Medical Group, Inc.

MetricTOI (Apr 24, 2026)MD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A11.88
Forward P/E i-21.509.90
PEG Ratio i-21.509.90
Price to Sales (TTM) i0.681.00
Price to Book (MRQ) i-20.912.16
Market Capitalization
Market Capitalization i$323.20M$1.91B
Enterprise Value i$410.19M$2.00B
Enterprise Value Metrics
Enterprise to Revenue i0.821.05
Enterprise to EBITDA i-14.087.92
Risk & Other Metrics
Beta i0.200.72
Book Value per Share (MRQ) i$-0.16$10.68

Financial Statements Comparison: The Oncology Institute Inc. vs Pediatrix Medical Group, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTOI (2025)MD (2025)
Revenue/Sales i502.73M1.91B
Cost of Goods Sold i426.29M1.42B
COGS % of Revenue i84.8%74.2%
Gross Profit i76.44M493.70M
Gross Margin i15.2%25.8%
Research & Development iN/AN/A
Operating Income (EBIT) i-36.08M231.09M
Operating Margin i-7.2%12.1%
EBITDA i-30.06M256.55M
EBITDA Margin i-6.0%13.4%
Pre-Tax Income i-60.74M216.43M
Pre-Tax Income % of Revenue i-12.1%11.3%
Income Tax i-131,00051.04M
Income Tax % of Revenue i0.0%2.7%
Net Income (Profit) i-60.61M165.39M
Profit Margin i-12.1%8.6%

Balance Sheet & Liquidity Metrics

MetricTOI (2025)MD (2025)
Cash & Equivalents i33.57M375.24M
Total Current Assets i112.75M763.51M
Total Current Assets % of Revenue i22.4%39.9%
Total Current Liabilities i70.96M458.91M
Total Current Liabilities % of Revenue i14.1%24.0%
Long-Term Debt i96.53M596.22M
Long-Term Debt % of Revenue i19.2%31.2%
Total Shareholders Equity i-15.72M865.85M
Retained Earnings i-271.42M-83.15M
Retained Earnings % of Revenue i-54.0%-4.3%
Property, Plant & Equipment i24.08M195.53M

Cash Flow Statement Comparison

MetricTOI (2025)MD (2025)
Operating Cash Flow i-41.02M270.23M
Operating Cash Flow % of Revenue i-8.2%14.1%
Capital Expenditures i-3.20M-18.46M
Free Cash Flow i-27.79M252.63M
FCF Margin i-5.5%13.2%
Debt Repayment i-20.04M-20.75M
Common Stock Repurchase iN/A-86.68M

Short Interest & Institutional Ownership Analysis

MetricTOIMD
Shares Short i8.30M3.53M
Short Ratio i3.363.77
Short % of Float i10.12%6.00%
Shares Outstanding i98.86M82.98M
Float Shares i64.83M79.95M
% Held by Insiders i20.14%2.31%
% Held by Institutions i45.02%106.63%
% Held by Public i34.84%-8.94%

Dividend Analysis & Yield Comparison: The Oncology Institute Inc. vs Pediatrix Medical Group, Inc.

MetricTOIMD
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A